Trending Alert: 4 HealthTech Tickers Trending Now

Names Inside If you cannot see this email properly, please click [here]( Powered by [HealthTechMovers.com]( Dear Reader, Below is a a list of 4 Healthtech Stocks that have appear to be trending by receiving buy ratings and showing positive investor sentiment, as well as news headlines. With that said, our editors are adding them to our watchlist to see if the momentum continues. --------------------------------------------------------------- Sponsor [What Happened to New Gold Discoveries?]( [See why savvy investors are looking at U.S. gold projects right now.]( --------------------------------------------------------------- [Conmed, CNMD]( Summary: CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery. Robbie Marcus analyst at J.P. Morgan reiterates coverage on [Conmed (CNMD)](in the Health sector with a Buy rating and has set a price target of $115. [TipRanks.com]( reports that [Conmed](currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $111.80. In addition, TradingView issued a Strong sell rating for [CNMD]( over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Neutral short-term outlook. [For the complete breakdown on CNMD, please click here >>]( --------------------------------------------------------------- [Kura Oncology, KURA]( Summary: Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California. Peter Lawson analyst at Barclays reiterates coverage on [Kura Oncology (KURA)](in the Health sector with a Buy rating and has set a price target of $32. [TipRanks.com]( reports that [Kura Oncology](currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $30.20. In addition, TradingView issued a buy rating for [KURA]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the complete breakdown on KURA, please click here >>]( --------------------------------------------------------------- Sponsor [The Gold Dilemma Nobody Told You About]( flock to gold during times of uncertainty, instability, and geopolitical crisis. We saw this with the COVID-19 pandemic, the Russia-Ukraine war, and now the Israel-Hamas conflict. While analysts are increasingly bullish on the yellow metal, new gold discoveries are urgently needed to meet the projected future demand. [Read about this potential new American gold hotspot.]( --------------------------------------------------------------- [Align Tech, ALGN]( Summary: Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services. Brandon Couillard analyst at Jefferies reiterates coverage on [Align Tech (ALGN)](in the Health sector with a Buy rating and has set a price target of $325. [TipRanks.com]( reports that [Align Tech](currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $334.60. In addition, TradingView issued a buy rating for [ALGN]( over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Bullish short-term outlook. [For the complete breakdown on ALGN, please click here >>]( --------------------------------------------------------------- [Thermo Fisher, TMO]( Summary: Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. Catherine Ramsey analyst at Robert W. Baird reiterates coverage on [Thermo Fisher (TMO)](in the Health sector with a Buy rating and has set a price target of $597. [TipRanks.com]( reports that [Thermo Fisher](currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $606.40. In addition, TradingView issued a buy rating for [TMO]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bearish short-term outlook. [For the complete breakdown on TMO, please click here >>]( --------------------------------------------------------------- Sponsor [Musk: My new robots could be bigger than Tesla]( No one can deny Elon Musk is a visionary. But has he finally gone too far? [>>See the shocking future of AI here<<]( --------------------------------------------------------------- --------------------------------------------------------------- Sponsor [More "Safe" Gold is Needed to Meet Growing Demand]( is an effective way to protect portfolios from the forces of war and uncertainty. But gold reserves have declined, along with a lack of new gold discoveries. To make up for growing gold demand, more new mining projects and gold discoveries are needed - particularly in safe jurisdictions such as the U.S. [See why American gold should be on every investor's radar.]( --------------------------------------------------------------- Remember, securities are volatile, so please do your own research. One resource you need to consider using [Tipranks.com]( where as a premium member you get access to all buy ratings, price targets and insider trading signals. [TipRanks.com]( tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. [Get more from TipRanks.com here >>]( Thanks for reading! The Editor, [HealthTechMovers.com]( --------------------------------------------------------------- Sponsor [Melting Glaciers Could Uncover Once-Hidden Minerals]( glaciers are a serious worry for climate scientists. But for miners exploring the "frozen north's" Golden Triangle, melting glaciers could help locate and extract both base and precious metals that were previously untouchable. [See how a changing climate could open up new resource investing opportunities.]( --------------------------------------------------------------- HealthTechMovers.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software